What does other generic revenues — net revenues mean?

This metric represents net revenue generated from established pharmaceutical brands, royalty streams, and ancillary pharmaceutical services outside of the company's primary generic product lines. It captures the performance of legacy assets and strategic partnerships that provide diversified income streams beyond standard generic drug manufacturing. Monitoring this revenue helps investors assess the stability and contribution of non-core business activities to the overall top-line performance.

ANI Pharmaceuticals ANIP Other generic revenues — Net Revenues

Similar metrics at other companies

BLCOBranded and Other Generics — Total revenues

$49M-9.3%

AMRXOther therapeutic classes — Net revenue

$13.95M+115%

AMRXOther dosage forms — Net revenue

$46.61M-17.4%

BCRXOther revenues — Total revenues

$5.05M-55.3%

BMYOther revenues — Total Revenues

$227M0.0%

ACIOther revenue — Net sales and other revenue

$193M+14.7%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.88B+18.3%

Enterprise value$1.87B+5.8%

P/E20.4×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's other generic revenues — net revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's other generic revenues — net revenues?: ANI Pharmaceuticals (ANIP) reported other generic revenues — net revenues of $3.82M in Q1 2026.
What does other generic revenues — net revenues mean?: This metric represents net revenue generated from established pharmaceutical brands, royalty streams, and ancillary pharmaceutical services outside of the company's primary generic product lines. It captures the performance of legacy assets and strategic partnerships that provide diversified income streams beyond standard generic drug manufacturing. Monitoring this revenue helps investors assess the stability and contribution of non-core business activities to the overall top-line performance.